TRIM22 Antibodies

Singh, Patel, Mureithi, Naranbhai, Ramsuran, Tulsi, Hiramen, Werner, Mlisana, Altfeld, Luban, Kasprowicz, Dheda, Abdool Karim, Ndungu: "TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment." in: Journal of virology, Vol. 88, Issue 8, pp. 4291-303, (2014) (PubMed).

Carotenuto, Pedone, Diana, de Antonellis, Džeroski, Marino, Navas, Di Dato, Scoppettuolo, Cimmino, Correale, Pirone, Monti, Bruder, Zenko, Slavkov, Pastorino, Ponzoni, Schulte, Schramm, Eggert et al.: "Neuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction. ..." in: Scientific reports, Vol. 3, pp. 1351, (2013) (PubMed).

Kajaste-Rudnitski, Pultrone, Marzetta, Ghezzi, Coradin, Vicenzi: "Restriction factors of retroviral replication: the example of Tripartite Motif (TRIM) protein 5 alpha and 22." in: Amino acids, Vol. 39, Issue 1, pp. 1-9, (2010) (PubMed).

Petersson, Lönnbro, Herr, Mörgelin, Gullberg, Drott: "The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase." in: Experimental cell research, Vol. 316, Issue 4, pp. 568-79, (2010) (PubMed).

Ovsyannikova, Dhiman, Haralambieva, Vierkant, OByrne, Jacobson, Poland: "Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes." in: Human genetics, Vol. 127, Issue 2, pp. 207-21, (2010) (PubMed).

Singh, Gaiha, Werner, McKim, Mlisana, Luban, Walker, Karim, Brass, Ndungu: "Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection." in: Journal of virology, Vol. 85, Issue 1, pp. 208-16, (2010) (PubMed).

Sivaramakrishnan, Sun, Rajmohan, Lin: "B30.2/SPRY domain in tripartite motif-containing 22 is essential for the formation of distinct nuclear bodies." in: FEBS letters, Vol. 583, Issue 12, pp. 2093-9, (2009) (PubMed).

Herr, Dressel, Walter: "Different subcellular localisations of TRIM22 suggest species-specific function." in: Immunogenetics, Vol. 61, Issue 4, pp. 271-80, (2009) (PubMed).

Eldin, Papon, Oteiza, Brocchi, Lawson, Mechti: "TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus." in: The Journal of general virology, Vol. 90, Issue Pt 3, pp. 536-45, (2009) (PubMed).

Ovsyannikova, Haralambieva, Dhiman, OByrne, Pankratz, Jacobson, Poland: "Polymorphisms in the vitamin A receptor and innate immunity genes influence the antibody response to rubella vaccination." in: The Journal of infectious diseases, Vol. 201, Issue 2, pp. 207-13, (2009) (PubMed).